April 23, 2023

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

Israeli startup Syqe® says it’s solved the problem of unpredictable and inconsistent medical cannabis treatment with the SyqeAir Inhaler and Cartridges that deliver the same dose of cannabis every time.

“I Wanted To Be In Control. Wanted The Pain To Go Away Without The Psychoactive Part”

10/04/2022

SyqeAir patients talk about the treatment utilizing the medical inhaler. From the moment the doctors suggested treatment using medical cannabis till now.

Long-Term Effectiveness and Safety of Medical Cannabis Administered through the Metered-Dose SyqeAir Inhaler

24/12/2025

Syqe®’s 2022 PAIN Reports study examined the long-term effectiveness and safety of medical cannabis treatment delivered via the metered-dose SyqeAir Inhaler under real-world conditions. Listen to the podcast.

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler

28/04/2021

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: April 23, 2023

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

Related Posts

“I Wanted To Be In Control. Wanted The Pain To Go Away Without The Psychoactive Part”

Long-Term Effectiveness and Safety of Medical Cannabis Administered through the Metered-Dose SyqeAir Inhaler

Syqe® Receives Health Canada Approval For Medical Cannabis Inhaler